Jason Luty is a specialist registrar in psychiatry (Marina House, Addictions Resource Centre, 63/65 Denmark Hill, Camberwell, London SE5 8RS, UK). He has published in the addictions field and is involved with the Maudsley Hospital Community Drug Team.
Treatment of illicit drug dependence typically involves a combination of pharmacotherapy and psychosocial interventions. Efficacy research supports methadone maintenance in opiate dependence. There is less evidence to support buprenorphine (an opiate receptor partial agonist), lofexidine (an
2-adrenoreceptor agonist) and naltrexone (an opiate receptor antagonist). Evidence for the effectiveness of detoxification, which one of the most widely used treatments, is poor. Of the psychosocial interventions, reasonable evidence exists for the effectiveness of motivational interviewing. Other psychosocial treatments have rarely been compared with no or minimal contact conditions in randomised trials, and their reported effectiveness is often weak. Residential treatments are not demonstrably more effective than community programmes.
This article has been cited by other articles:
![]() |
C. Littlewood A new buprenorphine prescribing service for opiate detoxification Psychiatr. Bull., March 1, 2007; 31(3): 91 - 93. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Shastry Sanctions on clients who use opiates on top of methadone Psychiatr. Bull., February 1, 2007; 31(2): 77 - 77. [Full Text] [PDF] |
||||
![]() |
E. Day and S. George Management of drug misuse in pregnancy Adv. Psychiatr. Treat., July 1, 2005; 11(4): 253 - 261. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Gordon and D. Haider The use of 'drug dogs' in psychiatry Psychiatr. Bull., June 1, 2004; 28(6): 196 - 198. [Full Text] [PDF] |
||||
![]() |
N. Seivewright INVITED COMMENTARY ON: What works in drug addiction? Adv. Psychiatr. Treat., July 1, 2003; 9(4): 287 - 288. [Full Text] [PDF] |
||||